Valeant Pharmaceuticals reported $582M in Cost of Sales for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Amgen AMGN:US $ 1609M 28M
Ani Pharmaceuticals ANIP:US $ 24.41M 2.1M
Aphria Inc APH:CN C$ 160.92M 13.78M
Aurora Cannabis Inc ACB:CN 46M 69.67M
Biogen BIIB:US $ 511.8M 52.1M
Bristol Myers Squibb BMY:US $ 2291M 160M
Canopy Growth Corp WEED:CN C$ 202.51M 93.54M
Catalent CTLT:US $ 701M 47.9M
Corcept Therapeutics CORT:US $ 1.27M 0.11M
Danaher DHR:US $ 2870M 49M
Eli Lilly And LLY:US $ 1430.8M 522.4M
Endo International Ordinary Shares ENDP:US $ 297.12M 16.31M
Gilead Sciences GILD:US $ 1223M 167M
Gw Pharmaceuticals GWPH:US $ 11.81M 1.39M
Horizon Pharma HZNP:US $ 251.64M 50.64M
JAZZ PHA JAZZ:US $ 145.22M 26.03M
Lannett LCI:US $ 85M 1.65M
Nektar Therapeutics NKTR:US $ 5.31M 2.36M
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Perrigo Ordinary Shares PRGO:US $ 706.3M 74.2M
Phibro Animal Health PAHC:US $ 149.99M 0.46M
Prestige Brands PBH:US $ 118.51M 8.34M
Revance Therapeutics RVNC:US $ 5.89M 460K
Supernus Pharmaceuticals SUPN:US $ 18.08M 6.94M
Valeant Pharmaceuticals VRX:CN $ 582M 30M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M
Zoetis ZTS:US $ 582M 18M